PSI
IHE icon

Pinnacle Summer Investments’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Pinnacle Summer Investments’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-378
Closed -$22K – 1014
2015
Q2 		$22K Buy
+378
New +$22.1K ﹤0.01% 414

Other funds holding IHE

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BCM
Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return
AWA
ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return
BWM
Braver Wealth Management Needham, Massachusetts $616M AUM 12.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
SFI
SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Pinnacle Summer Investments's IHE Position: Q3 2015 in Review

Pinnacle Summer Investments sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2015, closing a stake of 378 shares — an estimated $22K sold.

Pinnacle Summer Investments first reported a position in IHE in Q2 2015 and held it in 1 quarter. The position peaked at $22K in Q2 2015. 102 funds tracked by Wall St. Rank hold IHE as of Q3 2015.

  • Pinnacle Summer Investments reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2015 after selling out during the quarter.
  • Pinnacle Summer Investments sold 378 iShares US Pharmaceuticals ETF shares in Q3 2015, an estimated $22K.
  • Pinnacle Summer Investments first reported a position in iShares US Pharmaceuticals ETF in Q2 2015 and held it in 1 quarter.
  • Pinnacle Summer Investments's iShares US Pharmaceuticals ETF position peaked at $22K in Q2 2015.
  • 102 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2015.

Based on Pinnacle Summer Investments's 13F filing for Q3 2015, filed 2 Nov 2015.